1-[(3aR,8aR)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 97%, 1g

(R)-N-Methyl-1-phenylethanamine hydrochloride, 95.0%, 10g

Flacons à fond rond à trois cols cols latéraux parallèles, 250 ml, 24/29, 19/26, 1 pièce

4-(3-Fluorophenyl)-4-oxobutyronitrile, 97.0%, 5g

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 1g

methyl 4-hydroxybicyclo[2.2.2]octane-1-carboxylate, 97.0%, 25g

Tige de chrome 99,95% 1 mm diamètre 50 mm

(+)-Dehydroabietylamine [Optical Resolving Agent]>90.0%(GC)25g

4-(2-METHOXYETHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

Ethyl 2-(4-chloro-3-fluoro-phenoxy)acetate, 97.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 250mg

6H-Purin-6-one, 9-[[2-(acetyloxy)ethoxy]methyl]-2-amino-1,9-dihydro-, 97%, 250mg

2,4-Difluoro-3-hydroxybenzaldehyde, 95.0%, 25g